Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Marksteiner

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
Biogerontology|May 8, 2015
Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's diseaseBarbara Plagg, Josef Marksteiner, Kathrin M Kniewallner, et al.
Journal of Molecular Neuroscience : MN|April 5, 2002
Synaptic proteins in Alzheimer's diseaseJosef Marksteiner, Walter A Kaufmann, Peter Gurka, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 3, 2011
Chromogranin peptides in brain diseasesMichael Willis, Irmgard Leitner, Kurt A Jellinger, et al.
The Primary Care Companion for CNS Disorders|April 14, 2017
Depressive Symptoms and Their Interactions With Emotions and Personality Traits Over Time: Interaction Networks in a Psychiatric ClinicLaura N Semino, Josef Marksteiner, Gernot Brauchle, et al.
Frontiers in Neurology|June 30, 2020
Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid AngiopathyBettina M Foidl, Herbert Oberacher, Josef Marksteiner, et al.
Metabolomics : Official Journal of the Metabolomic Society|December 19, 2017
Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's diseaseJosef Marksteiner, Imrich Blasko, Georg Kemmler, et al.
Journal of Neurochemistry|May 22, 2009
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patientsChristoph Zenzmaier, Josef Marksteiner, Andreas Kiefer, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|March 4, 2008
Separation anxiety disorder and school refusal in childhood: potential risk factors for developing distinct psychiatric disorders?Karl Karlovec, Kurosch Yazdi, Ulrike Rier, et al.
Brain Research|February 8, 2003
Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine actionWalter A Kaufmann, Christian Humpel, George F Alheid, et al.
Drug Safety|July 1, 2006
Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?Wolfgang Aichhorn, Alexandra B Whitworth, Elisabeth M Weiss, et al.
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Biogerontology|May 8, 2015
Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's diseaseBarbara Plagg, Josef Marksteiner, Kathrin M Kniewallner, et al.
Journal of Molecular Neuroscience : MN|April 5, 2002
Synaptic proteins in Alzheimer's diseaseJosef Marksteiner, Walter A Kaufmann, Peter Gurka, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 3, 2011
Chromogranin peptides in brain diseasesMichael Willis, Irmgard Leitner, Kurt A Jellinger, et al.
The Primary Care Companion for CNS Disorders|April 14, 2017
Depressive Symptoms and Their Interactions With Emotions and Personality Traits Over Time: Interaction Networks in a Psychiatric ClinicLaura N Semino, Josef Marksteiner, Gernot Brauchle, et al.
Frontiers in Neurology|June 30, 2020
Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid AngiopathyBettina M Foidl, Herbert Oberacher, Josef Marksteiner, et al.
Metabolomics : Official Journal of the Metabolomic Society|December 19, 2017
Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's diseaseJosef Marksteiner, Imrich Blasko, Georg Kemmler, et al.
Journal of Neurochemistry|May 22, 2009
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patientsChristoph Zenzmaier, Josef Marksteiner, Andreas Kiefer, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|March 4, 2008
Separation anxiety disorder and school refusal in childhood: potential risk factors for developing distinct psychiatric disorders?Karl Karlovec, Kurosch Yazdi, Ulrike Rier, et al.
Brain Research|February 8, 2003
Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine actionWalter A Kaufmann, Christian Humpel, George F Alheid, et al.
Drug Safety|July 1, 2006
Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?Wolfgang Aichhorn, Alexandra B Whitworth, Elisabeth M Weiss, et al.
Pageof 15